The Food and Drug Administration has halted operations at a Delaware cheese plant after an outbreak of listeria linked to the company’s cheese killed one person and sickened seven others.
A powerful new prescription painkiller is set to hit pharmacy shelves in the next couple of weeks and that has some law enforcement officials in the Philadelphia region very concerned.
Coming up with the best treatment plan for Alzheimer’s disease can be tricky because there are so many variables among patients including aging and overall health.
The analysis is the first to examine recent national trends in caffeine intake among children and young adults and comes amid a U.S. Food and Drug Administration investigation into the safety of caffeine-containing foods and drinks, especially for children and teens.
Pro-Pet LLC is voluntarily recalling the products, which tested positive for salmonella.
Reading food labels could soon be a lot easier.
There is a new non-surgical breakthrough in veterinary medicine that has just recently emerged as an alternative to a surgical procedure when neutering male dogs.
Antibacterial soap may cause more harm than good according to the Food and Drug Administration, which today proposed new regulations.
CBS3’s investigative reporter Charlotte Huffman goes undercover to learn more about the supplement that has sent many people to the emergency room.
A European version of the “morning-after pill” that is identical in formula to Plan B One-Step in the U.S. will update its packaging to show that it is not effective in women over 176 pounds.
If you bake, you probably use enriched flour. But, legally, what does that mean?
It’s not the cigarettes, but new research indicates teens are increasingly smoking e-cigarettes, cigars and hookah.
Federal health officials have agreed to import a meningitis vaccine approved in Europe and Australia but not the U.S. as officials at Princeton University consider measures to stop the spread of the disease on the Ivy League campus.
The FDA announced it will require the food industry to gradually phase out trans fats because they’re dangerous.
Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations of promoting three prescription drugs for off-label uses not approved by the Food and Drug Administration, the Department of Justice announced on Monday.